Ok how about this as a starting point?
Amplia Therapeutics Annual Report YE 31/3/23 pg48 “going concern” and audit report pg65
Pharmaxis AR YE 30/6/23 pg33 “going concern” and audit report pg62
Mesoblast AR YE 30/6/24 pg6 “Risks; accumulated deficit $908.8 million; require substantial additional financing” and pg169 “going concern - material uncertainty”
Neuren Pharmaceuticals AR YE 31/12/20 pg36 “material uncertainties and going concern basis”
Actinogen Medical AR YE 30/6/23 pg43 “going concern” and audit report pg64
I think you now owe me an apology and you need to consider retracting your comments in relation to my post!
Screenshot(s) from Annual Report of 29 Aug 24, page-10
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
-0.005(2.44%) |
Mkt cap ! $36.11M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 20.0¢ | 19.0¢ | $19.42K | 101.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8208 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 9829 | 1 |
View Market Depth
| Last trade - 15.42pm 03/09/2024 (20 minute delay) ? |
| CYP (ASX) Chart |